Carlyle-Backed Resonetics Acquires Resolution Medical, Expands Cleanroom Assembly
Carlyle-backed Resonetics completed the acquisition of Resolution Medical, adding biosimulation, design, new product introduction and cleanroom assembly to its device manufacturing portfolio. The deal expands end-to-end integrated capabilities across interventional, structural heart and neuromodulation markets, aiming to accelerate commercialization and reduce program complexity.
1. Acquisition Completion
Resonetics has finalized the acquisition of Resolution Medical, integrating the firm’s biosimulation, design, new product introduction and cleanroom assembly capabilities into its operations. The deal extends Resonetics’ end-to-end service offering across interventional, structural heart and neuromodulation device segments.
2. Expanded Manufacturing Capabilities
By combining Resolution Medical’s engineering and cleanroom assembly expertise with Resonetics’ precision component manufacturing, advanced materials and battery technologies, the company now supports full product lifecycles from concept through scaled production. Customers can leverage AGILE Product Development alongside enhanced sub-assembly and finished device services.
3. Strategic Impact
The acquisition strengthens Resonetics’ position in high-growth interventional and neuromodulation markets by reducing program complexity and accelerating device commercialization. Backed by Carlyle and GTCR, the expanded platform bolsters the firm’s medtech portfolio and enhances its value proposition for OEM partners.